Pharmacological effects on 35% CO₂ panic induction: A meta-analysis.

Area of Science:

• Psychopharmacology
• Neuroscience
• Clinical Psychology

Background:

• Inhalation of 35% carbon dioxide (CO2) reliably triggers fear and physiological responses similar to panic attacks (PAs).
• The CO2 model is crucial for studying panic disorder (PD) and evaluating pharmacological interventions.
• Previous research has not comprehensively quantified the effects of various drugs on CO2-induced panic responses.

Purpose of the Study:

• To systematically quantify the impact of pharmacological interventions on the physiological and psychological responses to 35% CO2 inhalation.
• To consolidate evidence from existing studies to provide a robust estimate of treatment effects.
• To assess the efficacy of different drug classes in mitigating experimental panic.

Main Methods:

• A systematic literature search was conducted to identify relevant peer-reviewed studies.
• Multilevel meta-analyses were employed to synthesize data from 36 studies involving 980 participants.
• Effect sizes were calculated for self-reported anxiety and panic attack symptoms following pharmacological interventions.

Main Results:

• Pharmacological interventions aimed at symptom reduction significantly decreased induced anxiety (effect size = -0.55) and panic attack symptoms (effect size = -0.31).
• Interventions targeting the serotonergic system demonstrated a pronounced reduction in induced anxiety (effect size = -0.81).
• Data from 980 participants (patients with panic disorder and healthy controls) were analyzed.

Conclusions:

• The findings support the utility of the 35% CO2 challenge as a valid experimental model for investigating panic disorder.
• Specific pharmacological agents can effectively reduce sensitivity to CO2-induced panic, validating their therapeutic potential.
• This meta-analysis provides quantitative evidence for the role of specific drug mechanisms in modulating panic responses.